Abstract: A method of modulating a physiological parameter of a patient by percutaneously or transcutaneously disabling one or more pre-aortic ganglion cells within a pre-aortic ganglion via the anterior abdominal wall and improving the physiological parameter is provided. The pre-aortic ganglion cells may be disabled by applying radiofrequency, high intensity or low intensity focused ultrasound.
Type:
Application
Filed:
March 14, 2013
Publication date:
December 12, 2013
Applicant:
ENIGMA MEDICAL, INC.
Inventors:
Denise Barbut, Allan Rozenberg, Axel Heinemann
Abstract: A method of modulating a physiological parameter of a patient is provided. The method includes disabling one or more pre-aortic ganglion cells within a pre-aortic ganglion and improving the physiological parameter. The method further includes destroying a pre-aortic ganglion cell to prevent regeneration.
Type:
Application
Filed:
March 6, 2013
Publication date:
November 7, 2013
Applicant:
ENIGMA MEDICAL, INC.
Inventors:
Denise Barbut, Allan Rozenberg, Axel Heinemann
Abstract: A method of modulating a physiological parameter of a patient is provided. The method includes disabling one or more pre-aortic ganglion cells within a pre-aortic ganglion trans-venously and improving the physiological parameter. The method further includes destroying a pre-aortic ganglion cell trans-venously to prevent regeneration.
Type:
Application
Filed:
March 6, 2013
Publication date:
November 7, 2013
Applicant:
ENIGMA MEDICAL, INC.
Inventors:
Denise Barbut, Allan Rozenberg, Axel Heinemann
Abstract: A method of ablating the sympathetic ganglionic cell bodies in the thoracic paravertebral space is provided. The method includes ablating the sympathetic ganglionic cell bodies in the thoracic paravertebral space through a posterior, non-invasive or minimally invasive approach for the treatment of resistant hypertension. The ablation may additionally involve various permutations of the gray and white rami and the dorsal root ganglion in addition to the sympathetic chain ganglionic cell bodies, all located in the triangular paravertebral space.
Type:
Application
Filed:
March 6, 2013
Publication date:
November 7, 2013
Applicant:
Enigma Medical, Inc.
Inventors:
Denise Barbut, Allan Rozenberg, Axel Heinimann